P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL

• E. K. Mai,
• U. Bertsch,
• R. Fenk,
• D. Tichy,
• B. Besemer,
• J. Dürig,
• R. Schroers,
• I. von Metzler,
• M. Hänel,
• C. Mann,
• A. M. Asemissen,
• B. Heilmeier,
• E. Nievergall,
• S. Huhn,
• K. Kriegsmann,
• N. Weinhold,
• S. Luntz,
• T. A. W. Holderrried,
• K. Trautmann-Grill,
• D. Gezer,
• M. Klaiber-Hakimi,
• M. Müller,
• C. Khandanpour,
• W. Knauf,
• C. Scheid,
• M. Munder,
• T. Geer,
• H. Riesenberg,
• J. Thomalla,
• M. Hoffmann,
• M. S. Raab,
• H. J. Salwender,
• K. C. Weisel,
• H. Goldschmidt

Affiliations

E. K. Mai

1 Department of Internal Medicine V, University Hospital Heidelberg

U. Bertsch

1 Department of Internal Medicine V, University Hospital Heidelberg

R. Fenk

3 Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf

D. Tichy

4 Division of Biostatistics, erman Cancer Research Center (DKFZ) Heidelberg, Heidelberg

B. Besemer

5 Department of Internal Medicine II, University Hospital Tübingen, Tübingen

J. Dürig

6 Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen

R. Schroers

7 Medical Clinic, University Hospital Bochum, Bochum

I. von Metzler

8 Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main

M. Hänel

9 Department of Internal Medicine III, Clinic Chemnitz, Chemnitz

C. Mann

10 Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg

A. M. Asemissen

11 Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg

B. Heilmeier

12 Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg

E. Nievergall

1 Department of Internal Medicine V, University Hospital Heidelberg

S. Huhn

1 Department of Internal Medicine V, University Hospital Heidelberg

K. Kriegsmann

1 Department of Internal Medicine V, University Hospital Heidelberg

N. Weinhold

1 Department of Internal Medicine V, University Hospital Heidelberg

S. Luntz

13 Coordination Centre for Clinical Trails (KKS) Heidelberg, Heidelberg

T. A. W. Holderrried

14 Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn

K. Trautmann-Grill

15 Department of Internal Medicine I, University Hospital Dresden, Dresden

D. Gezer

16 Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen

M. Klaiber-Hakimi

17 Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf

M. Müller

18 Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Hannover

C. Khandanpour

19 Medical Clinic A, niversity Hospital Münster, Münster

W. Knauf

20 Center for Hematology and Oncology Bethanien, Frankfurt am Main

C. Scheid

21 Department of Internal Medicine I, University Hospital Cologne, Cologne

M. Munder

22 Department of Internal Medicine III, University Hospital Mainz, Mainz

T. Geer

23 Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall

H. Riesenberg

24 Hematology / Oncology Center, Bielefeld

J. Thomalla

25 Hematology / Oncology Center, Koblenz

M. Hoffmann

26 Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen

M. S. Raab

1 Department of Internal Medicine V, University Hospital Heidelberg

H. J. Salwender

27 Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany

K. C. Weisel

11 Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg

H. Goldschmidt

1 Department of Internal Medicine V, University Hospital Heidelberg